Skip to main content

NACFC Main banner

Icon Legend

Food/Drinks Available

CE's Available

Reception

Pre-registration Required

Livestreaming

Recorded Session

Back

Tweet this

Michelle Stevens-Brogan

Aridis Pharmaceuticals, Inc.

Poster(s):

(507) PHASE 1/2a RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY: SAFETY, PK, AND EFFICACY OUTCOME MEASURES OF INHALED GALLIUM CITRATE (AR-501) IN CYSTIC FIBROSIS PATIENTS
Thursday, November 3, 2022
12:45 PM – 1:25 PM ET